PharmaJet announces availability of quadrivalent influenza vaccine
OLDEN, Colo. — PharmaJet, the maker of needle-free injection technology, on Tuesday announced that shipping has begun for the quadrivalent influenza vaccine for needle-free delivery with the PharmaJet Stratis device for the 2017-18 influenza season.
"Adding a quadrivalent influenza vaccine to the already available trivalent vaccine offering with our needle-free delivery means healthcare providers and patients now have a choice of vaccines for the upcoming flu season," stated Ron Lowy, PharmaJet chairman and CEO. "Not only does needle-free offer an alternative for those 25% of adults that fear needles, but it also gives pharmacies and flu clinic providers a way to differentiate their flu immunization program, and a way to drive increased immunization rates and store traffic."
PharmaJet offers the only needle-free delivery system cleared by the FDA for administration of inactivated influenza vaccines, the company stated.